UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An improved correspondence formula for AdS/CFT with multi-trace operators

Physics letters. B, 2002-04, Vol.531 (3-4), p.301-304

Mück, Wolfgang

2002

Volltextzugriff (PDF)

Effective fluid description of the dark universe

Physics letters. B, 2018-01, Vol.776 (C), p.242-248

2018

Volltextzugriff (PDF)

Conformal field theory correlators from classical scalar field theory on anti–de Sitter space

Physical review. D, Particles and fields, 1998-08, Vol.58 (4), Article 041901

1998

Volltextzugriff (PDF)

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

The European respiratory journal, 2009-04, Vol.33 (4), p.785-792

2009

Volltextzugriff (PDF)

On the phase transition of conformal field theories with holographic duals

Physics letters. B, 2001-12, Vol.522 (1-2), p.139-144

2001

Volltextzugriff (PDF)

Progress on holographic three-point functions

Fortschritte der Physik, 2005-07, Vol.53 (7-8), p.948-954

Mück, W.

2005

Volltextzugriff (PDF)

Holographic renormalization and Ward identities with the Hamilton–Jacobi method

Classical and quantum gravity, 2003-06, Vol.20 (12), p.S559-S566

M ck, W

2003

Volltextzugriff (PDF)

Geodesics and Newton’s law in brane backgrounds

Physical review. D, Particles and fields, 2000-11, Vol.62 (10), Article 105019

2000

Volltextzugriff (PDF)

Clinical pharmacokinetics of cerivastatin

Clinical pharmacokinetics, 2000-08, Vol.39 (2), p.99-116

MÜCK, W

2000

Volltextzugriff (PDF)

Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

European journal of clinical pharmacology, 1998-02, Vol.53 (6), p.469-473

1998

Volltextzugriff (PDF)

Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS)

Pharmazie, 1999-09, Vol.54 (9), p.639-644

MÜCK, W

1999

Volltextzugriff (PDF)

Inter‐ethnic comparisons of the pharmacokinetics of the HMG‐CoA reductase inhibitor cerivastatin

British journal of clinical pharmacology, 1998-06, Vol.45 (6), p.583-590

1998

Volltextzugriff (PDF)

Consistent linearized gravity in brane backgrounds

Nuclear physics. B, 2000-12, Vol.590 (1), p.273-286

2000

Volltextzugriff (PDF)

Tacrolimus/cerivastatin interaction study in liver transplant recipients

British journal of clinical pharmacology, 2001-08, Vol.52 (2), p.213-217

2001

Volltextzugriff (PDF)

Clinical-pharmacological stratégies to assess drug interaction potential during drug development

Drug safety, 2001, Vol.24 (10), p.715-725

2001

Volltextzugriff (PDF)

Enantiospecific determination of nimodipine in human plasma by liquid chromatography-tandem mass spectrometry

Journal of Chromatography A, 1995-09, Vol.712 (1), p.45-53

Mück, Wolfgang M.

1995

Volltextzugriff (PDF)

Regular and irregular boundary conditions in the AdS-CFT correspondence

Physical review. D, Particles and fields, 1999-10, Vol.60 (8), Article 081901

1999

Volltextzugriff (PDF)

Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients

Clinical pharmacology and therapeutics, 1999-03, Vol.65 (3), p.251-261

1999

Volltextzugriff (PDF)

Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin

International journal of clinical pharmacology and therapeutics, 1997-06, Vol.35 (6), p.255

1997

Volltextzugriff (PDF)

Grapefruit juice increases oral nimodipine bioavailability

International journal of clinical pharmacology and therapeutics, 1998-03, Vol.36 (3), p.126

1998

Volltextzugriff (PDF)

Calculated spin polarization and magnetic dichroism of photoelectron diffraction spectra for magnetite below the Verwey temperature

Physical review. B, Condensed matter, 1996-06, Vol.53 (21), p.14262-14267

1996

Volltextzugriff (PDF)

Pharmacokinetics of cerivastatin when administered under fasted and fed conditions in the morning or evening

International journal of clinical pharmacology and therapeutics, 2000-06, Vol.38 (6), p.298-303

2000

Volltextzugriff (PDF)

Riociguat bei Patienten mit pulmonaler Hypertonie aufgrund einer chronisch obstruktiven Lungenerkrankung (PH-COPD)

Pneumologie (Stuttgart, Germany), 2011-11, Vol.65 (S 02), p.S125-S126

2011

Volltextzugriff (PDF)

Biopharmaceutical Profile of Cerivastatin: A Novel HMG-CoA Reductase Inhibitor

Journal of International Medical Research, 1999-05, Vol.27 (3), p.107-114

1999

Volltextzugriff (PDF)

Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin

International journal of clinical pharmacology and therapeutics, 1997-06, Vol.35 (6), p.261

1997

Volltextzugriff (PDF)

1 – 25 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(219)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(240)
Deutsch
(53)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An improved correspondence formula for AdS/CFT with multi-trace operators

Effective fluid description of the dark universe

Conformal field theory correlators from classical scalar field theory on anti–de Sitter space

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

On the phase transition of conformal field theories with holographic duals

Progress on holographic three-point functions

Holographic renormalization and Ward identities with the Hamilton–Jacobi method

Geodesics and Newton’s law in brane backgrounds

Clinical pharmacokinetics of cerivastatin

Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS)

Inter‐ethnic comparisons of the pharmacokinetics of the HMG‐CoA reductase inhibitor cerivastatin

Consistent linearized gravity in brane backgrounds

Tacrolimus/cerivastatin interaction study in liver transplant recipients

Clinical-pharmacological stratégies to assess drug interaction potential during drug development

Enantiospecific determination of nimodipine in human plasma by liquid chromatography-tandem mass spectrometry

Regular and irregular boundary conditions in the AdS-CFT correspondence

Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients

Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin

Grapefruit juice increases oral nimodipine bioavailability

Calculated spin polarization and magnetic dichroism of photoelectron diffraction spectra for magnetite below the Verwey temperature

Pharmacokinetics of cerivastatin when administered under fasted and fed conditions in the morning or evening

Riociguat bei Patienten mit pulmonaler Hypertonie aufgrund einer chronisch obstruktiven Lungenerkrankung (PH-COPD)

Biopharmaceutical Profile of Cerivastatin: A Novel HMG-CoA Reductase Inhibitor

Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin

Suchergebnisse filtern